TY - JOUR
T1 - Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice
AU - McConnell, Bradley K.
AU - Jones, Karen A.
AU - Fatkin, Diane
AU - Arroyo, Luis H.
AU - Lee, Richard T.
AU - Aristizabal, Orlando
AU - Turnbull, Daniel H.
AU - Georgakopoulos, Dimitrios
AU - Kass, David
AU - Bond, Meredith
AU - Niimura, Hideshi
AU - Schoen, Frederick J.
AU - Conner, David
AU - Fischman, Donald H.
AU - Seidman, Christine E.
AU - Seidman, Jonathan G.
PY - 1999/11
Y1 - 1999/11
N2 - To elucidate the role of cardiac myosin-binding protein-C (MyBP-C) in myocardial structure and function, we have produced mice expressing altered forms of this sarcomere protein. The engineered mutations encode truncated forms of MyBP-C in which the cardiac myosin heavy chain-binding and titin- binding domain has been replaced with novel amino acid residues. Analogous heterozygous defects in humans cause hypertrophic cardiomyopathy. Mice that are homozygous for the mutated MyBP-C alleles express less than 10% of truncated protein in M-bands of otherwise normal sarcomeres. Homozygous mice bearing mutated MyBP-C alleles are viable but exhibit neonatal onset of a progressive dilated cardiomyopathy with prominent histopathology of myocyte hypertrophy, myofibrillar disarray, fibrosis, and dystrophic calcification. Echocardiography of homozygous mutant mice showed left ventricular dilation and reduced contractile function at birth; myocardial hypertrophy increased as the animals matured. Left-ventricular pressure-volume analyses in adult homozygous mutant mice demonstrated depressed systolic contractility with diastolic dysfunction. These data revise our understanding of the role that MyBP-C plays in myofibrillogenesis during cardiac development and indicate the importance of this protein for long-term sarcomere function and normal cardiac morphology. We also propose that mice bearing homozygous familial hypertrophic cardiomyopathy-causing mutations may provide useful tools for predicting the severity of disease that these mutations will cause in humans.
AB - To elucidate the role of cardiac myosin-binding protein-C (MyBP-C) in myocardial structure and function, we have produced mice expressing altered forms of this sarcomere protein. The engineered mutations encode truncated forms of MyBP-C in which the cardiac myosin heavy chain-binding and titin- binding domain has been replaced with novel amino acid residues. Analogous heterozygous defects in humans cause hypertrophic cardiomyopathy. Mice that are homozygous for the mutated MyBP-C alleles express less than 10% of truncated protein in M-bands of otherwise normal sarcomeres. Homozygous mice bearing mutated MyBP-C alleles are viable but exhibit neonatal onset of a progressive dilated cardiomyopathy with prominent histopathology of myocyte hypertrophy, myofibrillar disarray, fibrosis, and dystrophic calcification. Echocardiography of homozygous mutant mice showed left ventricular dilation and reduced contractile function at birth; myocardial hypertrophy increased as the animals matured. Left-ventricular pressure-volume analyses in adult homozygous mutant mice demonstrated depressed systolic contractility with diastolic dysfunction. These data revise our understanding of the role that MyBP-C plays in myofibrillogenesis during cardiac development and indicate the importance of this protein for long-term sarcomere function and normal cardiac morphology. We also propose that mice bearing homozygous familial hypertrophic cardiomyopathy-causing mutations may provide useful tools for predicting the severity of disease that these mutations will cause in humans.
UR - http://www.scopus.com/inward/record.url?scp=0032741970&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032741970&partnerID=8YFLogxK
U2 - 10.1172/JCI7377
DO - 10.1172/JCI7377
M3 - Article
C2 - 10545522
AN - SCOPUS:0032741970
SN - 0021-9738
VL - 104
SP - 1235
EP - 1244
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 9
ER -